Idexx expands test menu for the catalyst platform to support veterinarians globally in diagnosing pancreatitis

The launch of the catalyst® pancreatic lipase test demonstrates idexx's technology for life strategy and will provide veterinarians with quantitative results at the point-of-care in less than 10 minutes  westbrook, maine , june 4, 2024 /prnewswire/ -- idexx laboratories, inc. (nasdaq: idxx), a global leader in pet healthcare innovation, announces the launch of the catalyst® pancreatic lipase test, a single-slide solution for canine and feline patients suspected of pancreatitis. with the innovative load-and-go workflow of the catalyst analyzers, the test can run effortlessly alongside chemistry profiles, leading to a faster path to diagnosis and enhanced patient outcomes.
IDXX Ratings Summary
IDXX Quant Ranking